Finucane Anne A.
SEC Form 4 insider trading activity
Finucane Anne A. has filed 5 SEC Form 4 filings (20 transaction rows) across 2 companies, including WSM, CVS, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Oct 16, 2026.
On the most recent filing, Finucane Anne A. is listed as Director at WILLIAMS SONOMA INC. Inside the rolling window, Finucane Anne A. reported no open-market purchases and 1 open-market sale totaling $200K in WSM.
Companies traded
Other insiders at WSM
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$200K
reported sales (SEC code S)
Companies
2
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Aug 20, 2025 | CVS | Sale | $533K |
Frequently asked questions
How many SEC Form 4 filings has Finucane Anne A. made?
Finucane Anne A. has filed 5 SEC Form 4 filings (20 transaction rows) across 2 companies, including WSM, CVS since 2025.
Which companies does Finucane Anne A. trade?
Finucane Anne A. has filed SEC Form 4 disclosures for 2 companies, including WSM, CVS.
When was Finucane Anne A.'s most recent SEC Form 4 filing?
Finucane Anne A.'s most recent SEC Form 4 filing on Tracefour is dated Oct 16, 2026.
What is Finucane Anne A.'s total buy and sell value in the current window?
Inside the rolling retention window, Finucane Anne A. bought $0 and sold $200K based on SEC Form 4 filings.
What was Finucane Anne A.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 794 WSM shares on 2026-10-16, worth $200K, per SEC Form 4 filings.